L-759,633

L-759,633 is a drug that acts as a potent and selective agonist for the cannabinoid receptor CB2, with reasonable selectivity over the psychoactive CB1 receptor, though with some variation between species. It has analgesic effects in animal studies, particularly for "atypical" pain conditions like chronic and neuropathic pain, where many other analgesics are ineffective.

Pharmacology

L-759,633 is a cannabinoid drug that has been developed for its potential therapeutic applications. It is a potent and selective agonist for the CB2 receptor, which is primarily found in the peripheral tissues of the body, rather than in the brain. This means that L-759,633 can produce its therapeutic effects without causing the psychoactive effects that are associated with activation of the CB1 receptor.

Therapeutic Applications

The primary potential therapeutic application of L-759,633 is as an analgesic. It has been found to be effective in animal studies for treating various types of pain, including chronic pain and neuropathic pain. These are types of pain that are often difficult to treat with other analgesics, so L-759,633 could potentially fill an important gap in the treatment options available for these conditions.

Side Effects

As a CB2 receptor agonist, L-759,633 is not expected to produce the psychoactive side effects that are associated with CB1 receptor agonists. However, the potential side effects of L-759,633 have not been fully studied, so it is not yet known what side effects it might have.

Research

Research into the potential therapeutic applications of L-759,633 is ongoing. It is hoped that this research will lead to the development of new treatments for conditions that are currently difficult to treat with existing analgesics.

L-759,633 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia